Partell Specialty Pharmacy (One Way Drug, LLC), Las Vegas, NV

Is Partell Specialty Pharmacy (One Way Drug, LLC) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Partell Specialty Pharmacy (One Way Drug, LLC) hold a Nevada pharmacy license?

State board of pharmacy records for Nevada are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026 (it takes requests for discipline records); its license verification is an interactive search. The Texas State Board of Pharmacy also lists nonresident license 26369 for PARTELL SPECIALTY PHARMACY, LAS VEGAS, NV, status Revocation, as of Nov 15, 2026. The Colorado State Board of Pharmacy also lists nonresident license OSP 6350 for Partell Specialty Pharmacy, Las Vegas, NV, status Expired and license OSP 6351 for Partell Specialty Pharmacy, Las Vegas, NV, status Expired, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054018733 for ONE WAY DRUG LLC, LAS VEGAS, NV, status CHANGE OF OWNERSHIP, license 054018734 for ONE WAY DRUG LLC, LAS VEGAS, NV, status CLOSED, license 054020497 for ONE WAY DRUG LLC, LAS VEGAS, NV, status NOT RENEWED and license 054020655 for ONE WAY DRUG LLC, LAS VEGAS, NV, status NOT RENEWED, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0002710 for PARTELL SPECIALTY PHARMACY, LAS VEGAS, NV, status INACTIVE and license PCN.0003345 for ONE WAY DRUG LLC (dba PARTEL SPECIALTY PHARMACY), LAS VEGAS, NV, status INACTIVE (EXPIRED MORE THAN 3 YEARS - MUST REAPPLY), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0002064 for Partell Specialty Pharmacy, LAS VEGAS, NV, status Closed, as of Nov 10, 2026.

Has Partell Specialty Pharmacy (One Way Drug, LLC) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Mar 13, 2019), 1 warning letter close-out (Jun 16, 2020), 1 state referral letter (Jun 16, 2020) and 1 FMD-145 letter (Jun 16, 2020) for Partell Specialty Pharmacy (One Way Drug, LLC). State board of pharmacy records for Nevada are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026 (it takes requests for discipline records); its license verification is an interactive search. The Colorado State Board of Pharmacy’s license dataset also lists “CLS Letter of Admonition” dated Apr 22, 2026, case 2025-5663 on nonresident license OSP 6351. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
One Way Drug, LLC; Partell Specialty Pharmacy
Location
Las Vegas, NV
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
1
Latest action on that page
Jun 16, 2020
FDA Data Dashboard inspections
2 inspections: 2 OAI; 2 published Form 483s
Form 483 text on this page
1 Form 483, 3 observations
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as One Way Drug, LLC, (dba Partell Specialty Pharmacy), a 503A facility, with 5 dated actions.

Document
Jun 16, 2020State referral letterState Referral Letter Issued 06/16/2020Not linked by FDA
Jun 16, 2020FMD-145 letterFMD-145 Letter Issued 6/16/2020FDA copy (archived)
Jun 16, 2020Warning letter close-outWarning Letter Close Out Issued 06/16/2020Not linked by FDA
Nov 25, 2019Form 483483 Issued 11/25/2019fda.gov
Mar 13, 2019Warning letterWarning Letter (03/13/2019)fda.gov

A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists One Way Drug, LLC, Las Vegas, NV (FEI number 3010839113); One Way Drug, Las Vegas, NV (FEI number 3011769075), matched to this page by exact name, city and state. It lists 2 inspections: 2 OAI at those sites, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile (FEI 3010839113). Dashboard firm profile (FEI 3011769075).

Inspection endedClassificationProject area and product typeFEIInspection ID
Jul 19, 2017Official Action Indicated (OAI)Drug Quality Assurance (Drugs)30108391131018429
May 30, 2014Official Action Indicated (OAI)Drug Quality Assurance (Drugs)3010839113882562

Form 483s FDA has published for these sites

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 3 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Jul 17, 2017 to Jul 19, 2017: 3 observations

Firm on the cover
, Las Vegas, NV 89117-5481 '"'
FEI number
3010839113
Establishment type on the cover
Producer of Non-sterile Drugs
FDA district office on the cover
1431 Harbor Bay Parkway Alameda, CA 94502-7070
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

Written procedures are not established for the cleaning and maintenance ofe quipment, including utensils, used in the manufacture, processing, packing or holding of a drug product

Specifically, Your firm has not established written and approved procedures for the cleaning of equipment and utensils used in the preparation of drug products. During the inspection, we observed the cleaning of the following equipment and utensils used in non-sterile production of your drug products: <Redacted B4> blender for powders, capsule press, glassware, and spatulas. We observed your lab technician using <Redacted B4> to wash and rinse glassware. We additionally observed your lab technician using the vacuum cleaner to vacuum your <Redacted B4> brand powder press followed by wiping with <Redacted B4>. Your firm has no evidence to show that your cleaning procedures are adequate in the removal of residual products and the removal of sanitizing agents. ...

Read the full 483 (PDF on fda.gov)

Observation 2

Drug products failing to meet established specifications are not rejected.

Specifically,

A. Your firm has not established written procedures to assure that expired finished products stored at your firm have the identity, strength, quality, and purity they purport to possess prior to releasing the product for patient use. The following expired finished products were not rejected and were observed stored in your firm's area for released finished products:

Finished Product

Lot#

Discard Date

BI /B2/B3/B5/B6,

20170407<@.31

DMSO in water

20170712@27

HCG, 200U/0.25 ml SL drops

20170505@58

Indole-3-carbinol 300 mg capsule

20161220@73

Betaine HCL/PEPSIN 250 mg/ I50mg

20170112@71

Trimix #4

[email protected]

Observation 3

Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the final specifications and identity and strength of each active ingredient prior to release.

Specifically,

A. Your firm has not established acceptable levels of microorganisms within each drug product. Your firm has also failed to test finished drug products for acceptable levels and the presence of objectionable microorganisms.

B. Your firm has not established written procedures for assay or potency testing ofyour finished drug products to assure they conform to appropriate specifications ofidentity, strength, quality, or purity. Your lab manager stated that there are no procedures, and that potency testing is conducted on a random schedule with randomly selected drug products.

or purity. Your lab manager stated that there are no procedures, and that potency testing is conducted on a random schedule with randomly selected drug products.

a. Specifically, your firm was notified that the potency of Estradiol was out-of-specification (OOS) at 114.1% and 114.901' respectfully (specification requirements <Redacted B4> for product, "Estra 0. ...

Read the full 483 (PDF on fda.gov)

Linked 483s whose text is not shown

State board of pharmacy records

State board of pharmacy records for Nevada are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026 (it takes requests for discipline records); its license verification is an interactive search.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).

LicenseType as the board gives itName on the board recordLocationStatusPrior disciplinary orders (file flag)
26369Non-Resident (Not Located in Texas)PARTELL SPECIALTY PHARMACYLAS VEGAS, NVRevocationYes

Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).

LicenseType as the board gives itName on the board recordLocationStatus
OSP 6350OSPPartell Specialty PharmacyLas Vegas, NVExpired
OSP 6351OSPPartell Specialty PharmacyLas Vegas, NVExpired

Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).

LicenseType as the board gives itName on the board recordLocationStatus
054018733LICENSED PHARMACYONE WAY DRUG LLCLAS VEGAS, NVCHANGE OF OWNERSHIP
054018734LICENSED PHARMACYONE WAY DRUG LLCLAS VEGAS, NVCLOSED
054020497LICENSED PHARMACYONE WAY DRUG LLCLAS VEGAS, NVNOT RENEWED
054020655LICENSED PHARMACYONE WAY DRUG LLCLAS VEGAS, NVNOT RENEWED

Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).

LicenseType as the board gives itName on the board recordLocationStatus
PCN.0002710NONRESIDENT PHARMACYPARTELL SPECIALTY PHARMACYLAS VEGAS, NVINACTIVE
PCN.0003345NONRESIDENT PHARMACYONE WAY DRUG LLC (dba PARTEL SPECIALTY PHARMACY)LAS VEGAS, NVINACTIVE (EXPIRED MORE THAN 3 YEARS - MUST REAPPLY)

Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).

LicenseType as the board gives itName on the board recordLocationStatus
A9-0002064Non Resident PharmacyPartell Specialty PharmacyLAS VEGAS, NVClosed

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.